NEW YORK, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
Danske Bank A/S (OTCMKTS: DNKEY)
Class Period: Purchasers of American Depositary Receipts between January 9, 2014 and October 23, 2018
Lead Plaintiff Deadline: March 11, 2019
Join the action: https://www.zlk.com/pslra-1/danske-bank-a-s-loss-form?wire=3
About the lawsuit: During the class period, Danske Bank A/S allegedly made materially false and/or misleading statements and/or
failed to disclose that: (i) Danske Bank’s Estonian branch was facilitating money laundering through at least March 2016; (ii) a
whistleblower had reported the Estonian money laundering to the Company in 2013; (iii) Denmark’s Financial Supervisory Authority
(the “DFSA”) had been investigating the Estonian money laundering since 2014; (iv) Danske Bank had concealed the results of its own
internal investigation from the DFSA, further exposing it to regulatory action and fines; (v) Danske Bank had been overstating its
historical profits by including the profits derived from its illicit Estonian operations; and (vi) Danske Bank lacked effective
internal and reporting controls.
To learn more about the Danske Bank A/S class action contact jlevi@levikorsinsky.com.
YRC Worldwide Inc. (NASDAQGS: YRCW)
Class Period: March 10, 2014 - December 14, 2018
Lead Plaintiff Deadline: March 4, 2019
Join the action: https://www.zlk.com/pslra-1/yrc-worldwide-inc-loss-form?wire=3
About the lawsuit: Throughout the class period, YRC Worldwide Inc. allegedly made materially false and/or misleading statements
and/or failed to disclose that: (1) from 2005 to at least 2013, YRC's units systematically overcharged the federal government for
freight carrier services; (2) this alleged misconduct caused the Department of Defense to overpay by millions of dollars for
shipments that were lighter, and thus cheaper, than the weights for which the government was charged; (3) consequently, this
alleged misconduct would subject YRC to enhanced government scrutiny and liabilities, including potentially owing treble damages
under the False Claims Act; and (4) as a result, the Company’s public statements were materially false and misleading at all
relevant times.
To learn more about the YRC Worldwide Inc. class action contact jlevi@levikorsinsky.com.
Molson Coors Brewing Company (NYSE: TAP)
Class Period: February 14, 2017 - February 12, 2019
Lead Plaintiff Deadline: April 16, 2019
Join the action: https://www.zlk.com/pslra-1/molson-coors-brewing-company-loss-form?wire=3
About the lawsuit: Molson Coors Brewing Company allegedly made materially false and/or misleading statements and/or failed to
disclose that: (1) Molson Coors failed to properly reconcile the outside basis deferred income tax liability for Molson Coors’
investment in its MillerCoors, LLC partnership; (2) consequently, Molson Coors misreported net income in its consolidated financial
statements for the fiscal years ending December 31, 2016 and December 31, 2017, resulting in an overall downward revision to net
income; (3) Molson Coors lacked adequate internal controls over financial reporting; and (4) as a result, defendants’ statements
about Molson Coors’ business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all
relevant times.
To learn more about the Molson Coors Brewing Company class action contact jlevi@levikorsinsky.com.
Amarin Corporation (NASDAQGM: AMRN)
Class Period: September 24, 2018 - November 9, 2018
Lead Plaintiff Deadline: April 23, 2019
Join the action: https://www.zlk.com/pslra-1/amarin-corporation-loss-form?wire=3
About the lawsuit: During the class period, Amarin Corporation allegedly made materially false and/or misleading statements
and/or failed to disclose that: (1) the top-line results Amarin touted about its REDUCE-IT trial for Vascepa were not as positive
as the company represented; (2) the placebo given to patients in the control arm of REDUCE-IT may have increased the incidence of
cardiovascular events in those patients; (3) as a result, Amarin's public statements were materially false and misleading at all
relevant times.
To learn more about the Amarin Corporation class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
